GPP
Great Point Partners’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-115,517
| Closed | -$4.36M | – | 34 |
|
|
2025
Q1 | $4.36M | Buy |
+115,517
| New | +$4.36M | 2.31% | 18 |
|
|
2024
Q1 | – | Sell |
-360,000
| Closed | -$22.6M | – | 39 |
|
|
2023
Q4 | $22.6M | Sell |
360,000
-171,211
| -32% | -$10.8M | 3.85% | 10 |
|
|
2023
Q3 | $27.1M | Sell |
531,211
-58,000
| -10% | -$2.96M | 4.93% | 4 |
|
|
2023
Q2 | $29.4M | Sell |
589,211
-70,000
| -11% | -$3.5M | 5.76% | 3 |
|
|
2023
Q1 | $24.7M | Sell |
659,211
-140,789
| -18% | -$5.28M | 4.85% | 6 |
|
|
2022
Q4 | $38.4M | Buy |
800,000
+200,000
| +33% | +$9.59M | 7.52% | 1 |
|
|
2022
Q3 | $14.4M | Sell |
600,000
-385,153
| -39% | -$9.24M | 3.47% | 11 |
|
|
2022
Q2 | $21.4M | Buy |
985,153
+100,000
| +11% | +$2.18M | 5.14% | 5 |
|
|
2022
Q1 | $21.4M | Buy |
885,153
+385,153
| +77% | +$9.3M | 5.17% | 10 |
|
|
2021
Q4 | $11.9M | Buy |
500,000
+401,939
| +410% | +$9.56M | 2.64% | 16 |
|
|
2021
Q3 | $2.49M | Buy |
+98,061
| New | +$2.49M | 0.58% | 30 |
|